[Cerebral toxoplasmosis in a patient with Waldenström's macroglobulinemia]

Enferm Infecc Microbiol Clin. 2014 Oct;32(8):549-50. doi: 10.1016/j.eimc.2014.03.016. Epub 2014 Jun 7.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antiprotozoal Agents / therapeutic use
  • Biopsy
  • Cross Infection / complications
  • Drug Therapy, Combination
  • Fatal Outcome
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Magnetic Resonance Imaging
  • Male
  • Multiple Organ Failure / etiology
  • Pneumonia / complications
  • Pons / parasitology
  • Pons / pathology
  • Pyrimethamine / therapeutic use
  • Sulfadiazine / therapeutic use
  • Toxoplasma / isolation & purification
  • Toxoplasmosis, Cerebral / complications*
  • Toxoplasmosis, Cerebral / diagnosis
  • Toxoplasmosis, Cerebral / drug therapy
  • Toxoplasmosis, Cerebral / parasitology
  • Waldenstrom Macroglobulinemia / complications*
  • Waldenstrom Macroglobulinemia / drug therapy

Substances

  • Antiprotozoal Agents
  • Immunosuppressive Agents
  • Sulfadiazine
  • Pyrimethamine